Strain Information | |
---|---|
Image | |
BRC No. | RBRC04503 |
Type | Targeted Mutation![]() |
Species | Mus musculus |
Strain name | B6.129P2-Smad7<tm1Tchi> |
Former Common name | Smad7 flox |
H-2 Haplotype | |
ES Cell line | E14 [129P2/OlaHsd] |
Background strain | |
Appearance | |
Strain development | Developed by Masayoshi Tojo and Tomoki Chiba, Graduate School of Life and Environmental Sciences in 2007. |
Strain description | Homozygous mutant mice are embryonic lethal. |
Colony maintenance | |
References | Smad7-deficient mice show growth retardation with reduced viability. Tojo M, Takebe A, Takahashi S, Tanaka K, Imamura T, Miyazono K, Chiba T J Biochem., 151 (6): 621-631 (2012). 22383537 |
Health Report | |
---|---|
Examination Date / Room / Rack |
Gene | |||||||
---|---|---|---|---|---|---|---|
Gene Symbol | Gene Name | Chr. | Allele Symbol | Allele Name | Common Names | Promoter | Diseases Related to This Gene |
Frt | yeast FRT (flippase recombination target) site | 18 | Frt | ||||
Frt | yeast FRT (flippase recombination target) site | 18 | Frt | ||||
Smad7 MGI:1100518 | SMAD family member 7 | 18 | Smad7<tm1Tchi> | targeted mutation 1, Tomoki Chiba | |||
loxP | phage P1 loxP | 18 | loxP | ||||
loxP | phage P1 loxP | 18 | loxP | ||||
neo | neomycin resistance gene (E. coli) | 18 | herpes simplex virus thymidine kinase promoter (HSV tk promoter) |
Phenotype | |
---|---|
Annotation by Mammalian phenotyhpe ontology | |
Detailed phenotype data |
Ordering Information | |
---|---|
Donor DNA | herpes simplex virus thymidine kinase promoter (HSV tk promoter), E. coli Neomycin resistance gene, phage P1 loxP sites, yeast FRT (flipase recombination target) sites, mouse Smad7 genomic DNA |
Research application | Cardiovascular Research Cre/loxP system FLP/frt system |
Specific Term and Conditions | Prior to requesting the BIOLOGICAL RESOURCE, the RECIPIENT must obtain approval from the DEPOSITOR using the Approval Form. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. The availability of the BIOLOGICAL RESOURCE is limited to a RECIPIENT of a not-for-profit institution for publication of research papers. For use of the BIOLOGICAL RESOURCE by a for-profit institution, the RECIPIENT must obtain a prior written consent on use of it from the DEPOSITOR. RECIPIENT must contact the DEPOSITOR in the case of application for any patents or commercial use based on the results from the use of the BIOLOGICAL RESOURCE. |
Depositor | Tomoki Chiba (University of Tsukuba) |
Strain Status | ![]() ![]() |
Strain Availability | Recovered litters from cryopreserved embryos (2 to 4 months) Cryopreserved sperm (within 1 month) Cryopreserved embryos (within 1 month) |
Additional Info. | Necessary documents for ordering:
Genotyping protocol -PCR- |
BRC mice in Publications |
---|
No Data |